Literature DB >> 9949293

Complications of subcutaneous infusion port in the general oncology population.

C Ballarini1, M Intra, A Pisani Ceretti, A Cordovana, M Pagani, G Farina, S Perrone, M Tomirotti, A Scanni, G P Spina.   

Abstract

Subcutaneous infusion ports (SIPs) represent a valid method for long-term chemotherapy. The SIPs have several advantages over other methods of venous access: they are easy to implant under local anaesthesia, have less discomfort for the patients, allow low costs, can be implanted in day hospital, and can be managed ambulatorily. However, SIPs have delayed complications, frequently related to clinical conditions of the neoplastic patients, and immediate complications, often due to the placement technique. From March 1992 to March 1997 we placed, under local anaesthesia and under fluoroscopic control, 102 SIPs in 99 general oncology patients for long-term chemotherapy (88% solid, 12% haematological tumours). The percutaneous venous access devices were in the subclavian vein in 96% of the cases and in the internal jugular vein in 4% of them. Immediate complications were: 1 haemopneumothorax, which required thoracic aspirations and two blood transfusions, 1 loop of the tunneled part of the catheter without alterations in SIP function, and 1 left jugular thrombosis in a patient with subclavian veins already thrombosed. The venous access was in the subclavian vein in the first 2 cases, and it was not necessary to suspend the therapeutic program. In the third instance, implanted in jugular vein, it was necessary to remove the SIP. Delayed complications were: 1 necrosis of the skin over the port, 1 infection of subcutaneous pocket, 2 infections of the system, 1 catheter deconnection, and 3 catheter ruptures with embolization of the catheter tip. The SIPs were removed in all cases but 1 in whom infection was successfully treated by appropriate antibiotic therapy. Embolization of the catheter required removal from the pulmonary artery under fluoroscopic guidance in the cardiac catheterization laboratory. In conclusion, infection and thrombosis are the two major complications of SIP in general oncology patients. In these cases it is not necessary to remove systematically the system, but a correct therapy (antibiotic, fibrinolytic agents) can be utilized with good results. The catheter rupture is often due to the wear over the costoclavicular angle. The interventional radiology is the method of choice in the treatment of the catheter embolization by rupture or dislocation. The experience of the surgical and nursing staff is probably the most important factor in decreasing the total rate of complications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9949293     DOI: 10.1159/000011947

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  22 in total

1.  Port-a-cath embolisation to pulmonary artery.

Authors:  Vijaya Raj Bhatt; Shilpi Gupta; Joseph Lowry; Meekoo Dhar
Journal:  BMJ Case Rep       Date:  2011-07-20

2.  Atypical pulmonary embolism of port catheter fragments in oncology patients.

Authors:  Alexey Surov; Karin Jordan; Michael Buerke; Monica Persing; Bettina Wollschlaeger; Curd Behrmann
Journal:  Support Care Cancer       Date:  2006-01-25       Impact factor: 3.603

3.  "Difficult to flush chemoport: an important clinical sign".

Authors:  Deepak Sundriyal; Sushil Jain; Suraj Manjunath
Journal:  Indian J Surg Oncol       Date:  2014-09-04

Review 4.  Totally implantable catheter migration and its percutaneous retrieval: case report and review of the literature.

Authors:  E Intagliata; F Basile; R Vecchio
Journal:  G Chir       Date:  2017 Sep-Oct

5.  A retained pulmonary artery catheter fragment incidentally found lodged in the right heart 16 years after its insertion.

Authors:  Sarah El-Heis; Julian O M Ormerod; Badri Chandrasekaran; Steve Ramcharitar
Journal:  BMJ Case Rep       Date:  2013-03-26

6.  Femoral Placement of Totally Implantable Venous Access Ports in Patients with Bilateral Breast Cancer.

Authors:  V Almasi-Sperling; S Hieber; J Lermann; O Strahl; M W Beckmann; W Lang; T A Sagban
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-01       Impact factor: 2.915

7.  Protocol for the implantation of a venous access device (Port-A-Cath System). The complications and solutions found in 560 cases.

Authors:  Luis Yeste Sánchez; José M Galbis Caravajal; Carlos A Fuster Diana; Enrique Moledo Eiras
Journal:  Clin Transl Oncol       Date:  2006-10       Impact factor: 3.405

8.  It appears to be safe to start chemotherapy on the day of implantation through subcutaneous venous port catheters in inpatient setting.

Authors:  Nuriye Yildirim Ozdemir; Hüseyin Abali; Berna Oksüzoğlu; Burçin Budakoğlu; Ilkay Akmangit; Nurullah Zengin
Journal:  Support Care Cancer       Date:  2008-09-02       Impact factor: 3.603

9.  Spontaneously migrated tip of an implantable port catheter into the axillary vein in a patient with severe cough and the subsequent intervention to reposition it.

Authors:  Kyung-Sik Ahn; Kweon Yoo; In Ho Cha; Tae-Seok Seo
Journal:  Korean J Radiol       Date:  2008-07       Impact factor: 3.500

10.  Internal jugular vein thrombosis presenting as a painful neck mass due to a spontaneous dislocated subclavian port catheter as long-term complication: a case report.

Authors:  Marcel Binnebösel; Jochen Grommes; Karsten Junge; Sonja Göbner; Volker Schumpelick; Son Truong
Journal:  Cases J       Date:  2009-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.